Inflammation-related and signaling proteins

Inflammation-related and signaling proteins represent a diverse functional class of molecules that coordinate the body's response to injury, infection, and cellular stress. This category encompasses secreted ligands such as cytokines and chemokines, transmembrane receptors like Toll-like receptors (TLRs) and cytokine receptors, and intracellular signaling components including Janus kinases (JAKs) and the NF-kappaB transcription factor complex (Source: Nature Reviews Immunology, 2017). These proteins are critical for maintaining homeostasis but are frequently dysregulated in chronic inflammatory conditions, autoimmune disorders, and various cancers (Source: StatPearls, 2023). Therapeutic strategies often involve the use of monoclonal antibodies to neutralize pro-inflammatory cytokines or small molecule inhibitors to disrupt intracellular signaling pathways (Source: PubMed, 2021). Because these proteins are essential for normal immune surveillance and host defense, pharmacological modulation can lead to significant safety concerns, most notably an increased susceptibility to opportunistic infections and potential impacts on wound healing (Source: NIH, 2022). As a target designation, this term is considered overly broad and does not refer to a single specific molecular entity suitable for precise drug-target profiling.

Other names

Inflammatory mediatorsPro-inflammatory signaling moleculesImmune signaling proteinsInflammatory signaling pathway components

Modulation of inflammatory cascades through cytokine neutralization, receptor blockade, or inhibition of intracellular signaling enzymes.